litlas
ログインアカウント作成

Peter A. Gottlieb

1987–2025 年に発表

86
論文数
18,503
被引用数
65
h 指数
80
i10 指数

被引用数

Peter A. Gottlieb の年別被引用数1990 年: 被引用 1 件1992 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 4 件1997 年: 被引用 3 件1998 年: 被引用 2 件1999 年: 被引用 3 件2000 年: 被引用 2 件2001 年: 被引用 17 件2002 年: 被引用 15 件2003 年: 被引用 19 件2004 年: 被引用 24 件2005 年: 被引用 35 件2006 年: 被引用 46 件2007 年: 被引用 84 件2008 年: 被引用 127 件2009 年: 被引用 140 件2010 年: 被引用 159 件2011 年: 被引用 137 件2012 年: 被引用 161 件2013 年: 被引用 170 件2014 年: 被引用 121 件2015 年: 被引用 193 件2016 年: 被引用 142 件2017 年: 被引用 151 件2018 年: 被引用 168 件2019 年: 被引用 562 件2020 年: 被引用 591 件2021 年: 被引用 677 件2022 年: 被引用 498 件2023 年: 被引用 517 件2024 年: 被引用 862 件2025 年: 被引用 490 件2026 年: 被引用 14 件1991 年は被引用が無いため表示していません1993〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,792 件、この内訳の 29.9%イギリス: 引用元論文 501 件、この内訳の 8.4%中国: 引用元論文 359 件、この内訳の 6%ドイツ: 引用元論文 340 件、この内訳の 5.7%イタリア: 引用元論文 316 件、この内訳の 5.3%カナダ: 引用元論文 279 件、この内訳の 4.7%オーストラリア: 引用元論文 258 件、この内訳の 4.3%フランス: 引用元論文 209 件、この内訳の 3.5%スウェーデン: 引用元論文 191 件、この内訳の 3.2%オランダ: 引用元論文 148 件、この内訳の 2.5%ベルギー: 引用元論文 123 件、この内訳の 2%フィンランド: 引用元論文 109 件、この内訳の 1.8%
0%29.9%その他 22.7%

機関

分野

  • Biochemistry, Genetics and Molecular Biology38.8%
  • Medicine32.7%
  • Immunology and Microbiology23.2%
  • Nursing1.8%
  • Neuroscience1%
  • Psychology0.7%
  • その他1.8%

トピック

  • Diabetes and associated disorders15.2%
  • Pancreatic function and diabetes10.3%
  • T-cell and B-cell Immunology9.9%
  • Immune Cell Function and Interaction9.3%
  • Diabetes Management and Research9%
  • Immunotherapy and Immune Responses3.1%
  • その他43.2%

共著者

全論文

検索で開く
  1. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

    著者: Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum - New England Journal of Medicine 2019 被引用: 1,112

  2. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association

    著者: Richard A. Insel, Jessica L. Dunne, Mark A. Atkinson, Jane L. Chiang, Dana Dabelea, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jeffrey P. Krischer, Åke Lernmark, Robert E. Ratner, Marian Rewers, Desmond Schatz, Jay S. Skyler, Jay M. Sosenko, Anette‐G. Ziegler - Diabetes Care 2015 被引用: 1,148

  3. Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

    著者: Emily K. Sims, Brian N. Bundy, Kenneth Stier, Elisavet Serti, Noha Lim, S. Alice Long, Susan Geyer, Antoinette Moran, Carla J. Greenbaum, Carmella Evans‐Molina, Kevan C. Herold, Type 1 Diabetes TrialNet Study Group, Linda A. DiMeglio, Stephen E. Gitelman, Peter A. Gottlieb, Jennifer B. Marks, Wayne D. Moore, Henry Rodriguez, William E. Russell, Desmond Schatz, Eva Tsalikian, Diane K. Wherrett, Anette‐Gabriele Ziegler - Science Translational Medicine 2021 被引用: 359

  4. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

    著者: Weihong Liu, Amy Putnam, Zhou Xu-yu, Gregory L. Szot, Michael R. Lee, Shirley Zhu, Peter A. Gottlieb, Philipp Kapranov, T Gingeras, Barbara Fazekas de St Groth, Carol Clayberger, David M. Soper, Steven F. Ziegler, Jeffrey A. Bluestone - The Journal of Experimental Medicine 2006 被引用: 2,584

  5. Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

    著者: Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Paula McGee, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, John M. Lachin, Jay S. Skyler - New England Journal of Medicine 2009 被引用: 1,073

  6. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

    著者: Manuela Battaglia, Simi Ahmed, Mark S. Anderson, Mark A. Atkinson, Dorothy Becker, Polly J. Bingley, Emanuele Bosi, Todd M. Brusko, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Carla J. Greenbaum, Peter A. Gottlieb, Kevan C. Herold, Martin J. Hessner, Mikael Knip, Laura M. Jacobsen, Jeffrey P. Krischer, S. Alice Long, Markus Lundgren, Eoin McKinney, Noel G. Morgan, Richard A. Oram, Tomi Pastinen, Michael C. Peters, Alessandra Petrelli, Xiaoning Qian, María J. Redondo, Bart O. Roep, Desmond Schatz, David Skibinski, Mark Peakman - Diabetes Care 2019 被引用: 344

  7. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    著者: Tihamer Orban, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Philip Raskin, Henry Rodriguez, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler - The Lancet 2011 被引用: 601

  8. Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial

    著者: Kevan C. Herold, Stephen E. Gitelman, Mario R. Ehlers, Peter A. Gottlieb, Carla J. Greenbaum, William Hagopian, Karen D. Boyle, Lynette Keyes-Elstein, Sudeepta Aggarwal, Deborah Phippard, Peter H. Sayre, James McNamara, Jeffrey A. Bluestone, and the AbATE Study Team - Diabetes 2013 被引用: 405

  9. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial

    著者: William E. Russell, Brian N. Bundy, Mark S. Anderson, Laura A. Cooney, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Michael J. Haller, Jeffrey P. Krischer, Ingrid Libman, Peter S. Linsley, S. Alice Long, Sandra Lord, Daniel J. Moore, Wayne V. Moore, Antoinette Moran, Andrew Muir, Philip Raskin, Jay S. Skyler, John M. Wentworth, Diane K. Wherrett, Darrell M. Wilson, Anette‐Gabriele Ziegler, Kevan C. Herold, Type 1 Diabetes TrialNet Study Group - Diabetes Care 2023 被引用: 96

  10. Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

    著者: Mark Rigby, Kristina M. Harris, Ashley Pinckney, Linda A. DiMeglio, Marc Rendell, Eric I. Felner, Jean M. Dostou, Stephen E. Gitelman, Kurt Griffin, Eva Tsalikian, Peter A. Gottlieb, Carla J. Greenbaum, Nicole Sherry, Wayne V. Moore, Roshanak Monzavi, Steven M. Willi, Philip Raskin, Lynette Keyes-Elstein, S. Alice Long, Sai Kanaparthi, Noha Lim, Deborah Phippard, Carol L. Soppe, Margret L. Fitzgibbon, James McNamara, Gerald T. Nepom, Mario R. Ehlers, the Immune Tolerance Network (ITN) T1DAL Study Group - Journal of Clinical Investigation 2015 被引用: 292

  11. Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function

    著者: Kevan C. Herold, Stephen E. Gitelman, Peter A. Gottlieb, Laura A. Knecht, Ralph Raymond, Eleanor L. Ramos - Diabetes Care 2023 被引用: 123

  12. Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

    著者: Michael J. Haller, Desmond Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Jessica Miller, Mark A. Atkinson, Dorothy J. Becker, David A. Baidal, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Jennifer B. Marks, Antoinette Moran, Henry Rodriguez, William E. Russell, Darrell M. Wilson, Carla J. Greenbaum, Type 1 Diabetes TrialNet ATG-GCSF Study Group, Carla J. Greenbaum, Mark A. Atkinson, David A. Baidal, M. Battaglia, Dorothy Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Mark A. Clements, Peter G. Colman, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Mikael Knip, J. Krischer, Åke Lernmark, W. Moore, Antoinette Moran, Andrew J. Muir, J. Palmer, Mark Peakman, Louis H. Philipson, Philip Raskin, María J. Redondo, Henry Rodriguez, W. J. Russell, Lisa M. Spain, Desmond Schatz, Jay M. Sosenko, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Mark S. Anderson, Peter A. Antinozzi, Christophe Benoıst, J.J. Blum, Kasia Bourcier, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, Catherine C. Cowie, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, L. Harrison, Bernhard J. Hering, Richard A. Insel, Sabine D. Jordan, Francine Kaufman, Tom Kay, Norma S. Kenyon, R. Klines, John M. Lachin, Ellen Leschek, Jeff Mahon, Jennifer B. Marks, Roshanak Monzavi, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, A. Pugliese, John A. Ridge, Bart O. Roep, Maria Grazia Roncarolo, Peter J. Savage, Olli Simell, R S Sherwin, Mark Siegelman, Jay S. Skyler, Andrea K. Steck, James W. Thomas, Massimo Trucco ほか 212 名 - Diabetes Care 2018 被引用: 180

  13. Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

    著者: Stephen E. Gitelman, Brian N. Bundy, Ele Ferrannini, Noha Lim, Lori Blanchfield, Linda A. DiMeglio, Eric I. Felner, Jason L. Gaglia, Peter A. Gottlieb, S. Alice Long, Andrea Mari, Raghavendra G. Mirmira, Philip Raskin, Srinath Sanda, Eva Tsalikian, John M. Wentworth, Steven M. Willi, Jeffrey P. Krischer, Jeffrey A. Bluestone, Mayalin Barr, Lori Blanchfield, Jeffrey A. Bluestone, Jeanne Buchanan, Brian N. Bundy, Joanne Cabbage, Peter G. Coleman, Monica De La Vega, Linda A. DiMeglio, Carmella Evans‐Molina, Eric I. Felner, Ele Ferrannini, Christine Ferrara, Jason L. Gaglia, Stephen E. Gitelman, Peter A. Gottlieb, Felicity Healy, Laurie Higgins, Megan Hildinger, Margaret A. Jenkins, Nora Bryant, Amanda Kinderman, Nisha Koshy, Brianne Kost, Jeffrey P. Krischer, Suzanne Krishfield, Olena Kucheruk, Noha Lim, Karen L. Lindsley, S. Alice Long, Manasa Mantravadi, Andrea Mari, Shelley Mesfin, Aaron W. Michels, Mary Ellen Migre, Pantea Minnock, Raghavendra G. Mirmira, Elham Mohammed-Nur, Jennifer B. Nelson, Ashvin Nursing, Ryan O’Donnell, Diana R. Olivos, Melissa M. Parker, Philip Raskin, Leanne Redl, Nicole Reed, Brittany Resnick, Srinath Sanda, Peter H. Sayre, Elisavet Serti, Emily Sims, Karen Smith, Carol L. Soppe, Fiona Stuart, Sarah Szubowicz, Michel Tansey, Jennifer Terrell, Sarah A. Tersey, Christine Torok, Eva Tsalikian, Kelly Watson, John M. Wentworth, Rebecca Wesch, Steven M. Willi, Stéphanie Woerner - The Lancet Diabetes & Endocrinology 2021 被引用: 133

  14. B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results

    著者: Mark D. Pescovitz, Carla J. Greenbaum, Brian N. Bundy, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler, the Type 1 Diabetes TrialNet Anti-CD20 Study Group - Diabetes Care 2013 被引用: 282

  15. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

    著者: María J. Redondo, Susan Geyer, Andrea K. Steck, Seth A. Sharp, John M. Wentworth, Michael N. Weedon, Peter A. Antinozzi, Jay M. Sosenko, Mark A. Atkinson, Alberto Pugliese, Richard A. Oram, Type 1 Diabetes TrialNet Study Group, Peter A. Antinozzi, Mark A. Atkinson, Manuela Battaglia, Dorothy J. Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Peter G. Colman, Peter A. Gottlieb, Kevan C. Herold, Richard A. Insel, Tom Kay, Mikael Knip, Jennifer B. Marks, Antoinette Moran, James L. Palmer, Mark Peakman, Louis H. Philipson, Alberto Pugliese, P. Raskin, Henry Rodriguez, Bart O. Roep, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Christophe Benoıst, J.J. Blum, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, Bernhard J. Hering, Francine Kaufman, Ellen Leschek, J. Mahon, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, Maria Grazia Roncarolo, Olli Simell, Robert Sherwin, Mark Siegelman, Andrea K. Steck, James W. Thomas, Massimo Trucco, J. Richard Wagner, Carla J. Greenbaum, Katarzyna Bourcier, Richard A. Insel, Jeffrey P. Krischer, Ellen Leschek, Lisa Rafkin, Lisa M. Spain, Catherine C. Cowie, Mary A. Foulkes, Heidi Krause‐Steinrauf, John M. Lachin, Saúl Malozowski, John Peyman, J P Ridge, Peter J. Savage, Jay S. Skyler, Stephanie J. Zafonte, Norma S. Kenyon, Irene Santiago, Jay M. Sosenko, Brian N. Bundy, Michael Abbondondolo, Timothy E. Adams, Darlene Amado, Ilma Asif, Matthew Boonstra, Brian N. Bundy, Cristina Burroughs, David Cuthbertson, Mary Deemer, Christopher Eberhard, Steve Fiske, Julie Ford, Jennifer Garmeson ほか 1,520 名 - Diabetes Care 2018 被引用: 169

  16. Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data

    著者: Michael J. Haller, S. Alice Long, J. Lori Blanchfield, Desmond Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Susan Geyer, Megan Warnock, Jessica Miller, Mark A. Atkinson, Dorothy J. Becker, David A. Baidal, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Jennifer B. Marks, Antoinette Moran, Henry Rodriguez, William E. Russell, Darrell M. Wilson, Carla J. Greenbaum, Type 1 Diabetes TrialNet ATG-GCSF Study Group, Carla J. Greenbaum, Mark A. Atkinson, David A. Baidal, Manuela Battaglia, Dorothy J. Becker, P. J. Bingley, Emanuele Bosi, Jane H. Buckner, Mark A. Clements, Peter G. Colman, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Robin Goland, Peter Gottlieb, Kevan C. Herold, Mikael Knip, Jeffrey P. Krischer, Åke Lernmark, Wayne D. Moore, Antoinette Moran, Andrew J. Muir, Jerry P. Palmer, Mark Peakman, Louis H. Philipson, Philip Raskin, María J. Redondo, Henry Rodriguez, William E. Russell, Desmond A. Schatz, Jay M. Sosenko, Lisa M. Spain, John M. Wentworth, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette G. Ziegler, Mark S. Anderson, Peter A. Antinozzi, Richard A. Insel, Thomas W. H. Kay, Jennifer B. Marks, Alberto Pugliese, Bart O. Roep, Jay S. Skyler, Jorma Toppari, Carla J. Greenbaum, Jeffrey P. Krischer, Ellen Leschek, Lisa Spain, Katarzyna Bourcier, Richard A. Insel, J P Ridge, Jay S. Skyler, Carla J. Greenbaum, Lisa Rafkin, Jay M. Sosenko, Jay S. Skyler, Irene Santiago, Jeffrey P. Krischer, Brian N. Bundy, Michael Abbondondolo, Timothy E. Adams, Ilma Asif, Jenna Bjellquist, Matthew Boonstra, Cristina Burroughs, Mario Cleves, David Cuthbertson, Meagan DeSalvatore, Christopher Eberhard, Steve Fiske, Julie Ford, Jennifer Garmeson, Susan Geyer ほか 178 名 - Diabetes 2019 被引用: 131

  17. Fall in C-Peptide During First 2 Years From Diagnosis

    著者: Carla J. Greenbaum, Craig A. Beam, David Boulware, Stephen E. Gitelman, Peter A. Gottlieb, Kevan C. Herold, John M. Lachin, Paula McGee, Jerry P. Palmer, Mark D. Pescovitz, Heidi Krause‐Steinrauf, Jay S. Skyler, Jay M. Sosenko, on behalf of the Type 1 Diabetes TrialNet Study Group - Diabetes 2012 被引用: 320

  18. Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial

    著者: Kevan C. Herold, Stephen E. Gitelman, Steven M. Willi, Peter A. Gottlieb, Frank Waldron-Lynch, Lesley Devine, Jennifer L. Sherr, S. M. Rosenthal, S. Adi, Muhammad Yazid Jalaludin, Aaron W. Michels, J. Dziura, Jeffrey A. Bluestone - Diabetologia 2012 被引用: 157

  19. Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis

    著者: the Immune Tolerance Network, Ana Luisa Perdigoto, Paula Preston‐Hurlburt, Pamela Clark, S. Alice Long, Peter S. Linsley, Kristina M. Harris, Steven Gitelman, Carla J. Greenbaum, Peter A. Gottlieb, William Hagopian, Alyssa Woodwyk, James Dziura, Kevan C. Herold - Diabetologia 2018 被引用: 125

  20. A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes

    著者: Christine Bender, Alice Wiedeman, Alex Hu, Alyssa Ylescupidez, William K. Sietsema, Kevan C. Herold, Kurt Griffin, Stephen E. Gitelman, S. Alice Long, on behalf of the T-Rex Study Group†, Peter A. Gottlieb, R. Strock, Lexie Chesshir, María J. Redondo, Christopher T. Williams, Mark A. Clements, Wayne V. Moore, Linda A. DiMeglio, Megan Legge, M. Mullen, Juan Manuel Sepúlveda-Sánchez, Maria Spall, Stéphanie Woerner, Jason L. Gaglia, Brittany Resnick, Nora Bryant, Suzanne Krishfield, J J Turley, Nisha Koshy, Mikayla Mackey, Ines Guttmann‐Bauman, Rebecca Fitch, Lynn Bartholow, John Shelso, Alaa Al Nofal, K. Hanisch, Luis E. De Las Casas, Brenda Thurlow, Michael Gottschalk, Marla Hashiguchi, Lisa Paglia, Angela Y. Lam, Srinath Sanda, Christine Torok, Rebecca Wesch, Daniel J. Moore, William E. Russell, Tyler Jordan Smith, Anne Brown, Faith Brendle, Michael J. Haller, Miriam Cintrón, David A. Baidal, Della Matheson, Carlos Blaschke, Antoinette Moran, Elizabeth Pappensus, Janice Leschyshyn, Anne Street - Science Translational Medicine 2024 被引用: 65

  21. Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    著者: Diane K. Wherrett, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Tihamer Orban, Jerry P. Palmer, Philip Raskin, Henry Rodriguez, Desmond Schatz, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler - The Lancet 2011 被引用: 369

  22. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

    著者: Janet M. Wenzlau, Kirstine Juhl, Liping Yu, Ong Moua, Suparna A. Sarkar, Peter A. Gottlieb, Marian Rewers, George S. Eisenbarth, Jan Jensen, Howard W. Davidson, John C. Hutton - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 被引用: 997

  23. Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes

    著者: Aimon K. Alkanani, Naoko Hara, Peter A. Gottlieb, Diana Ir, Charles E. Robertson, Brandie D. Wagner, Daniel N. Frank, Danny Zipris - Diabetes 2015 被引用: 297

  24. Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes

    著者: Ronnie Aronson, Peter A. Gottlieb, Jens Sandahl Christiansen, Thomas Donner, Emanuele Bosi, Bruce W. Bode, Paolo Pozzilli, the DEFEND Investigator Group - Diabetes Care 2014 被引用: 150